Next Article in Journal
Diagnostic Dilemma Posed by Severe Pelvic Actinomycosis Associated with Prolonged Use of Copper Intrauterine Contraceptive Device
Previous Article in Journal
Palmar Dislocation of Scaphoid and Lunate
 
 
Clinics and Practice is published by MDPI from Volume 11 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Long-Term Reversibility of Renal Dysfunction Associated to Light Chain Deposition Disease with Bortezomib and Dexamethasone and High Dose Therapy and Autologous Stem Cell Transplantation

by
Tomás J. González-López
1,
Lourdes Vázquez
1,
Teresa Flores
2,
Jesus Fernando San Miguel
1 and
Ramon García-Sanz
1,*
1
Hematology Department, Salamanca, Spain
2
Pathology Service, University Hospital of Salamanca, Salamanca, Spain
*
Author to whom correspondence should be addressed.
Clin. Pract. 2011, 1(4), e95; https://doi.org/10.4081/cp.2011.e95
Submission received: 19 September 2011 / Revised: 19 September 2011 / Accepted: 11 October 2011 / Published: 23 November 2011

Abstract

A 63-year-old woman presented with progressive renal insufficiency, until a glomerular filtration rate (GFR) of 12 mL/min. A renal biopsy demonstrated glomerular deposition of immunoglobulin k light chain. The presence of a small population of monoclonal plasmacytes producing an only light k monoclonal component was demonstrated and Bortezomib and Dexamethasone (BD) was provided as initial therapy. After seven courses of therapy, renal function improved without dialysis requirements up to a GFR 31 mL/min. Under hematological complete response (HCR) the patient underwent high dose of melphalan (HDM) and autologous peripheral blood stem cell transplant. Fifty-four months later the patient remains in HCR and the GFR has progressively improved up to 48 mL/min. This report describes a notably renal function improvement in a patient with Light Chain Deposition Disease after therapy with BD followed by HDM, which can support this treatment as a future option for these patients.
Keywords: light chain deposition disease; free light chain; monoclonal gammopathy; bortezomib; transplant light chain deposition disease; free light chain; monoclonal gammopathy; bortezomib; transplant

Share and Cite

MDPI and ACS Style

González-López, T.J.; Vázquez, L.; Flores, T.; San Miguel, J.F.; García-Sanz, R. Long-Term Reversibility of Renal Dysfunction Associated to Light Chain Deposition Disease with Bortezomib and Dexamethasone and High Dose Therapy and Autologous Stem Cell Transplantation. Clin. Pract. 2011, 1, e95. https://doi.org/10.4081/cp.2011.e95

AMA Style

González-López TJ, Vázquez L, Flores T, San Miguel JF, García-Sanz R. Long-Term Reversibility of Renal Dysfunction Associated to Light Chain Deposition Disease with Bortezomib and Dexamethasone and High Dose Therapy and Autologous Stem Cell Transplantation. Clinics and Practice. 2011; 1(4):e95. https://doi.org/10.4081/cp.2011.e95

Chicago/Turabian Style

González-López, Tomás J., Lourdes Vázquez, Teresa Flores, Jesus Fernando San Miguel, and Ramon García-Sanz. 2011. "Long-Term Reversibility of Renal Dysfunction Associated to Light Chain Deposition Disease with Bortezomib and Dexamethasone and High Dose Therapy and Autologous Stem Cell Transplantation" Clinics and Practice 1, no. 4: e95. https://doi.org/10.4081/cp.2011.e95

APA Style

González-López, T. J., Vázquez, L., Flores, T., San Miguel, J. F., & García-Sanz, R. (2011). Long-Term Reversibility of Renal Dysfunction Associated to Light Chain Deposition Disease with Bortezomib and Dexamethasone and High Dose Therapy and Autologous Stem Cell Transplantation. Clinics and Practice, 1(4), e95. https://doi.org/10.4081/cp.2011.e95

Article Metrics

Back to TopTop